Registry of Lobbyists

Advanced Registry Search Results

Search Criteria

Share this search Create an alert

Refine registrations results by

Status Type Subject matter Government institutions

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (142387)
Results: 1-50 | Export
  1. Association for Mountain Parks Protection & Enjoyment
    Type: Consultant
    Lobbyist: Philip Cartwright, Global Public Affairs
    Registration: 7 of 7 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  2. Automation Anywhere Inc.
    Type: Consultant
    Lobbyist: Nevin French, Edelman Canada
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 55
    Communication techniques: 3
    Government funding: No
  3. Electricity Distributors Association
    Type: Consultant
    Lobbyist: Roberto Chávez, Sussex Strategy Group
    Registration: 2 of 2 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 3
    Government institutions: 6
    Communication techniques: 2
    Government funding: No
  4. General Insurance OmbudService / Service de conciliation en assurance de dommages
    Type: Consultant
    Lobbyist: Suzanne Sabourin, Gowling WLG (Canada) LLP
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  5. Atlantic Power
    Type: Consultant
    Lobbyist: Roberto Chávez, Sussex Strategy Group
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  6. Bayshore HealthCare / Bayshore Soins de sante
    Type: In-house Corporation
    Responsible officer: Stuart Cottrelle, President
    Registration: 9 of 9 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 3
  7. Moderna Biopharma Canada Corporation
    Type: In-house Corporation
    Responsible officer: Stefan Raos, General Manager, Canada
    Registration: 14 of 14 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 8
  8. Black Diamond Group
    Type: Consultant
    Lobbyist: PHIL VON FINCKENSTEIN, Maple Leaf Strategies
    Registration: 4 of 4 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 7
    Communication techniques: 3
    Government funding: No
  9. HP Canada Co.
    Type: Consultant
    Lobbyist: Nevin French, Edelman Canada
    Registration: 2 of 2 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
  10. Cisco Systems Canada
    Type: Consultant
    Lobbyist: Nevin French, Edelman Canada
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 21
    Communication techniques: 2
    Government funding: No
  11. L-3 Technologies Canada
    Type: Consultant
    Lobbyist: Eric Fresque, CFN CONSULTANTS
    Registration: 2 of 2 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 5
    Communication techniques: 2
    Government funding: No
  12. General Dynamics Land Systems-Canada
    Type: Consultant
    Lobbyist: PHIL VON FINCKENSTEIN, Maple Leaf Strategies
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 16
    Communication techniques: 3
    Government funding: No
  13. Pathways to Education Canada / Passeport pour ma Reussite
    Type: In-house Organization
    Responsible officer: Tracey Taylor-O'Reilly, President and Chief Executive Officer
    Registration: 18 of 18 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 7
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 1
  14. Canadian Worker Co-operative Federation / La Fédération canadienne des coopératives de travail
    Type: In-house Organization
    Responsible officer: HAZEL CORCORAN, EXECUTIVE DIRECTOR
    Registration: 35 of 35 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 6
    Government institutions: 7
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 3
  15. Canadian Cardiovascular Society / Société canadienne de cardiologie
    Type: In-house Organization
    Responsible officer: Carolyn Pullen, Chief Executive Officer
    Registration: 16 of 16 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 4
    Government institutions: 14
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  16. GCT Global Container Terminals Inc.
    Type: Consultant
    Lobbyist: Philip Cartwright, Global Public Affairs
    Registration: 7 of 7 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  17. Enwave Energy Corporation
    Type: Consultant
    Lobbyist: Roberto Chávez, Sussex Strategy Group
    Registration: 4 of 4 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 2
    Government institutions: 9
    Communication techniques: 2
    Government funding: Yes
  18. Northern Road Link Project
    Type: Consultant
    Lobbyist: PHIL VON FINCKENSTEIN, Maple Leaf Strategies
    Registration: 3 of 3 (2024-04-23 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  19. Take a Hike Foundation
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 4 of 4 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 2
    Government institutions: 2
    Communication techniques: 3
    Government funding: Yes
  20. AbbVie Corporation
    Type: Consultant
    Lobbyist: Stephanie Levee, 3Sixty Public Affairs Inc.
    Registration: 4 of 4 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 7
    Government institutions: 9
    Communication techniques: 3
    Government funding: No
  21. Canadian Counselling and Psychotherapy Association / L’Association canadienne de counseling et de psychothérapie - Address & Client Representative
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 3
    Government institutions: 11
    Communication techniques: 3
    Government funding: No
  22. Ontario Federation of Agriculture (OFA)
    Type: Consultant
    Member of the board of directors/Member of the organization: Larry Davis
    Registration: 6 of 6 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 2
    Government institutions: 3
    Communication techniques: 3
    Government funding: No
  23. Vancouver Airport Authority
    Type: Consultant
    Lobbyist: Philip Cartwright, Global Public Affairs
    Registration: 8 of 8 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 4
    Government institutions: 10
    Communication techniques: 2
    Government funding: Yes
  24. Food Banks Canada / Banques alimentaires Canada
    Type: Consultant
    Lobbyist: CARLA VENTIN, GT & Company Executive Advisors
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 9
    Communication techniques: 2
    Government funding: Yes
  25. Alstom Transport Canada Inc.
    Type: Consultant
    Lobbyist: Victoria Jordan, Edelman
    Registration: 5 of 5 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  26. Infection Prevention and Control Canada / Prevention et Controle des Infections Canada
    Type: Consultant
    Lobbyist: Daniel Marino, IMPACT PUBLIC AFFAIRS
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  27. National Union of Public and General Employees / NUPGE
    Type: In-house Organization
    Responsible officer: Bert Blundon, President
    Registration: 27 of 27 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 35
    Government institutions: 13
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 6
  28. Infection Prevention and Control Canada / Prevention et Controle des Infections Canada
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  29. The Salvation Army Canada and Bermuda Territory
    Type: Consultant
    Lobbyist: Victoria Jordan, Edelman
    Registration: 6 of 6 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 4
    Government institutions: 11
    Communication techniques: 2
    Government funding: Yes
  30. University of Ontario Institute of Technology (operating as Ontario Tech University)
    Type: Consultant
    Lobbyist: Sonya Moore, Capital Hill Group
    Registration: 6 of 6 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 3
    Government institutions: 12
    Communication techniques: 2
    Government funding: Yes
  31. Frontier Duty Free Association / Association fontière hors taxes
    Type: Consultant
    Lobbyist: Daniel Marino, IMPACT PUBLIC AFFAIRS
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 4
    Government institutions: 18
    Communication techniques: 3
    Government funding: No
  32. Canadian Chiropractic Association / Association chiropratique canadienne
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 6
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  33. Canadian Seed Growers Association / Association canadienne des producteurs de semences
    Type: In-house Organization
    Responsible officer: Doug Miller, Executive Director
    Registration: 25 of 25 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 11
    Communication techniques: 3
    Government funding: Yes
    Employees who lobby: 4
  34. Association des chirurgiens dentistes du Québec
    Type: Consultant
    Member of the board of directors: Carl Tremblay
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 1
    Communication techniques: 2
    Government funding: No
  35. Pension Investment Association of Canada / Association canadienne des gestionnaires de caisses de retraite
    Type: In-house Organization
    Responsible officer: Peter Waite, Executive Director
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 7
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 1
  36. Canadian Dental Association / Association dentaire canadienne
    Type: Consultant
    Lobbyist: Victoria Jordan, Edelman
    Registration: 3 of 3 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 3
    Government institutions: 8
    Communication techniques: 2
    Government funding: No
  37. Canadian Council for Sustainable Aviation Fuels
    Type: Consultant
    Lobbyist: Kate Mah, PAA Advisory | Conseils
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: No
  38. Bayer CropScience Inc.
    Type: In-house Corporation
    Responsible officer: Antoine Bernet, President and Chief Executive Officer
    Registration: 25 of 25 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 6
    Government institutions: 10
    Communication techniques: 2
    Government funding: No
    Employees who lobby: 2
  39. The Boeing Company
    Type: Consultant
    Lobbyist: Dominic Besner, Summa Strategies Canada
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 4
    Government institutions: 9
    Communication techniques: 2
    Government funding: No
  40. triOS College Business Technology Healthcare Inc.
    Type: Consultant
    Lobbyist: Jacqueline LaRocque, Compass Rose Group
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 3
    Government institutions: 10
    Communication techniques: 3
    Government funding: No
  41. Intellectual Property Institute of Canada / L’Institut de la propriété intellectuelle du Canada
    Type: Consultant
    Lobbyist: Anastasios Housakos, IMPACT PUBLIC AFFAIRS
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  42. General Dynamics Land Systems-Canada
    Type: Consultant
    Lobbyist: Gordon Quaiattini, Maple Leaf Strategies
    Registration: 4 of 4 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 2
    Government institutions: 21
    Communication techniques: 2
    Government funding: No
  43. Gilead Sciences Canada
    Type: Consultant
    Lobbyist: Peter Cleary, Santis Health
    Registration: 3 of 3 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 2
    Communication techniques: 2
    Government funding: No
  44. Canada Workday ULC
    Type: Consultant
    Lobbyist: Fernando Minna, The Capital Hill Group
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 31
    Communication techniques: 2
    Government funding: No
  45. Scotts Canada Ltd.
    Type: Consultant
    Lobbyist: Sydney Linholm, Edelman Global Advisory
    Registration: 1 of 1 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 4
    Government institutions: 7
    Communication techniques: 2
    Government funding: No
  46. Tax-Filer Empowerment Canada
    Type: Consultant
    Lobbyist: Steve Van Groningen, PAA Advisory | Conseils
    Registration: 3 of 3 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 1
    Government institutions: 5
    Communication techniques: 3
    Government funding: No
  47. Diageo Canada
    Type: Consultant
    Lobbyist: Steve Van Groningen, PAA Advisory | Conseils
    Registration: 5 of 5 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 5
    Government institutions: 8
    Communication techniques: 2
    Government funding: Yes
  48. Canadian Women's Foundation
    Type: Consultant
    Lobbyist: Abigail Tait, Earnscliffe Strategies
    Registration: 2 of 2 (2024-04-22 to present)
    Posted: 2024-04-23
    Subject matter details: 9
    Government institutions: 16
    Communication techniques: 2
    Government funding: Yes
  49. Institute for Canadian Citizenship / Institut pour la citoyennete canadienne
    Type: Consultant
    Lobbyist: ISABEL METCALFE, Public Affairs Counsel
    Registration: 6 of 6 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 2
    Government institutions: 20
    Communication techniques: 3
    Government funding: Yes
  50. Canadian Window Covering Manufacturers Council
    Type: Consultant
    Lobbyist: Gordon Quaiattini, Maple Leaf Strategies
    Registration: 6 of 6 (2024-04-22 to present)
    Posted: 2024-04-22
    Subject matter details: 2
    Government institutions: 10
    Communication techniques: 2
    Government funding: No

Monthly communication reports (87)
Results: 1-50 | Export
  1. Québec Association of Pharmacy Distributors / Association québécoise des distributeurs en pharmacie
    Type: Consultant
    Lobbyist: Hugues Mousseau, Heyco Advisory Services Inc. / Cabinet conseil Heyco inc.
    Occurred: 2023-12-06
    Posted: 2023-12-08
    Designated public office holders:
    • Thomas Digby, Président, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Anie Perrault, Vice-présidente du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Carolyn Kobernick, Membre du Conseil, Conseil | Patented Medicine Prices Review Board (PMPRB)
    • Guillaume Couillard, Directeur exécutif par intérim, Conseil | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  2. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2023-10-06
    Posted: 2023-11-15
    Designated public office holders:
    • Guillaume Couillard, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Occurred: 2023-07-21
    Posted: 2023-08-01
    Designated public office holders:
    • Thomas Digby, Chairperson | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
    • Industry
  4. IQVIA Solutions Canada Inc.
    Type: In-house Corporation
    Occurred: 2023-05-17
    Posted: 2023-05-18
    Designated public office holders:
    • Thomas Digby, Chairperson to the Patented Medicine Prices Review Board (PMPRB) | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  5. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-12-05
    Posted: 2023-01-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • International Trade
    • Industry
    • Economic Development
    • Health
    • Taxation and Finance
    • Intellectual Property
    • Science and Technology
  6. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-12-05
    Posted: 2022-12-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  7. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2022-11-29
    Posted: 2022-12-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  8. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-10-27
    Posted: 2022-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  9. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-10-19
    Posted: 2022-11-14
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  10. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: WILLIAM DEMPSTER, 3Sixty Public Affairs Inc.
    Occurred: 2022-07-07
    Posted: 2022-08-15
    Designated public office holders:
    • Tanya Potashnik , Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • International Trade
    • Taxation and Finance
    • Intellectual Property
    • Science and Technology
    • Economic Development
    • Health
    • Industry
  11. RAREi - The Canadian Forum for Rare Disease Innovators / iRARE, le Forum canadien des innovateurs spécialisés dans les maladies rares
    Type: Consultant
    Lobbyist: GERALD JEFFCOTT, 3Sixty Public Affairs
    Occurred: 2022-07-07
    Posted: 2022-08-04
    Designated public office holders:
    • Tanya Potashnik, Director of Policy and Economic Analysis | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  12. Sun Life Financial Inc. / Financière Sun Life
    Type: In-house Corporation
    Occurred: 2022-06-10
    Posted: 2022-07-11
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  13. The Canada Life Assurance Company / de la Compagnie d'Assurance du Canada sur la Vie
    Type: In-house Corporation
    Occurred: 2022-06-07
    Posted: 2022-07-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  14. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2022-06-01
    Posted: 2022-06-30
    Designated public office holders:
    • Douglas Clark , Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  15. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-05-24
    Posted: 2022-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  16. AbbVie Corporation
    Type: In-house Corporation
    Occurred: 2022-04-14
    Posted: 2022-04-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
  17. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2022-04-07
    Posted: 2022-05-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  18. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2020-12-14
    Posted: 2020-12-14
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
    • Science and Technology
    • Research and Development
  19. Sunovion Pharmaceuticals Canada Inc.
    Type: Consultant
    Lobbyist: Kate Dalgleish, Compass Rose Group
    Occurred: 2020-12-09
    Posted: 2021-01-15
    Designated public office holders:
    • Elena Lungu, Manager, Policy Development | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnik, Director, Policy & Economic Analysis Branch | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Research and Development
    • Health
  20. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-22
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  21. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-10-07
    Posted: 2020-11-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  22. Vertex Pharmaceuticals (Canada) Incorporated
    Type: In-house Corporation
    Occurred: 2020-08-12
    Posted: 2020-09-09
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Health
  23. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-06-05
    Posted: 2020-07-14
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  24. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2020-05-15
    Posted: 2020-06-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Research and Development
    • Health
  25. Diabetes Canada / Diabète Canada
    Type: In-house Organization
    Occurred: 2020-01-22
    Posted: 2020-02-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  26. CANADIAN CANCER SOCIETY / Société canadienne du cancer
    Type: In-house Organization
    Occurred: 2019-12-10
    Posted: 2020-01-15
    Designated public office holders:
    • Douglas Clark, Executive Director, Exective Director's office | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  27. Takeda Canada Inc.
    Type: Consultant
    Lobbyist: Ian Chesney, Santis Health
    Occurred: 2019-07-29
    Posted: 2019-07-29
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Science and Technology
    • Research and Development
    • Budget
    • Economic Development
  28. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-05-29
    Posted: 2019-06-11
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  29. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2019-03-07
    Posted: 2019-03-18
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Research and Development
    • Industry
  30. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-12-11
    Posted: 2018-12-17
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    • Tanya Potashnick, Director | Patented Medicine Prices Review Board (PMPRB)
    • Matthew Kellison, Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  31. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-12-04
    Posted: 2019-01-13
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
  32. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-10-25
    Posted: 2018-11-01
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  33. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-09-11
    Posted: 2018-09-28
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  34. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2018-06-28
    Posted: 2018-07-05
    Designated public office holders:
    • Doug Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Science and Technology
    • Health
    • Research and Development
    • Economic Development
  35. Novo Nordisk Canada Inc.
    Type: In-house Organization
    Occurred: 2018-05-08
    Posted: 2018-09-07
    Designated public office holders:
    • Douglas Clark, Executive Director, PMPRB | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Economic Development
    • Research and Development
    • Intellectual Property
  36. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-04-10
    Posted: 2018-04-12
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry
  37. BIOTECANADA
    Type: In-house Organization
    Occurred: 2018-04-09
    Posted: 2018-05-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  38. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2018-03-07
    Posted: 2018-03-16
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  39. Novartis Pharmaceuticals Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-10-12
    Posted: 2017-11-15
    Designated public office holders:
    • Anju Dhillon, Member of Parliament - Dorval-Lachine-Lasalee | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Science and Technology
    • Industry
    • Health
    • Research and Development
  40. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-10-10
    Posted: 2017-10-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Health
  41. Hoffmann-La Roche Limited
    Type: In-house Corporation
    Occurred: 2017-07-26
    Posted: 2017-08-10
    Designated public office holders:
    • Douglas Clark, Executive Director, Patented Medicines Prices Review Board | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  42. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-05-23
    Posted: 2017-05-23
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Economic Development
    • Research and Development
    • Industry
    • Intellectual Property
    • Health
    • International Trade
  43. Amgen Canada Inc.
    Type: In-house Corporation
    Occurred: 2017-02-13
    Posted: 2017-03-15
    Designated public office holders:
    • Douglas Clark, Director General | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Health
  44. Bausch Health, Canada Inc. / Bausch Health, Canada Inc. Solutions de Sante
    Type: In-house Organization
    Occurred: 2016-11-22
    Posted: 2016-11-24
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
  45. Canadian Generic Pharmaceutical Association (CGPA) / L'Association canadienne du médicament générique (ACMG)
    Type: In-house Organization
    Occurred: 2016-10-12
    Posted: 2016-11-15
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Intellectual Property
  46. Apotex Inc.
    Type: In-house Corporation
    Occurred: 2016-10-12
    Posted: 2016-11-21
    Designated public office holders:
    • Doug Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Intellectual Property
    • Industry
  47. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-10-12
    Posted: 2016-11-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Industry
    • Intellectual Property
  48. Eli Lilly Canada Inc.
    Type: In-house Corporation
    Occurred: 2016-10-11
    Posted: 2016-11-14
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Economic Development
    • Research and Development
    • Health
    • Intellectual Property
    • Industry
  49. GlaxoSmithKline
    Type: In-house Corporation
    Occurred: 2016-07-14
    Posted: 2016-08-15
    Designated public office holders:
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Intellectual Property
    • Consumer Issues
    • Research and Development
  50. Teva Canada Limited / Teva Canada Limitee
    Type: In-house Corporation
    Occurred: 2016-06-07
    Posted: 2016-07-15
    Designated public office holders:
    • Jarrett Todd, Regulatory Officer | Patented Medicine Prices Review Board (PMPRB)
    • Ginette Tognet, Director, Regulatory Affairs & Outreach | Patented Medicine Prices Review Board (PMPRB)
    • Isabel Jaen Raasch, General Counsel | Patented Medicine Prices Review Board (PMPRB)
    • Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
    Subject matters:
    • Health
    • Industry

Date Modified: